e-Drug3D 939 |
TIGECYCLINE
|
cas 220620-09-7 |
CLASS ANTIINFECTIVES |
ROUTE (list) INTRAVENOUS |
ATC code |
PK parameters VD 639 LITER |
Target TARGET 30S RIBOSOMAL PROTEIN |
DrugCentral Unknown |
Download SDF file | N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxymethylidene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide Formula: Calculated chemical properties: MW 585.65 NB_atoms 42 XLogP 0.51 PSA 196.456 NB_HD 8 NB_HA 13 fsp3 0.52 Lipinski(0=no;1=yes) 0 |
FDA NDA 021821 (pdf not found) INN (TIGECYCLINE) TYGACIL (PF PRISM CV) APPROVAL= AP YEAR= 2005 NEWMOLECULARENTITY NDA 091620 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (SANDOZ) APPROVAL= AP YEAR= 2015 NDA 205645 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2016 NDA 208744 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (ACCORD HLTHCARE INC) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 204439 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (APOTEX) APPROVAL= AP YEAR= 2018 NDA 211158 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (AMNEAL) APPROVAL= AP YEAR= 2018 NDA 205722 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (XELLIA PHARMS APS) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 206335 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (EUGIA PHARMA) APPROVAL= AP YEAR= 2019 NDA 214020 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (MEITHEAL) APPROVAL= AP YEAR= 2021 |
Other links: |